GL1X · GenesisL1 explorer

UniProt P19803

Rho GDP-dissociation inhibitor 1 (P19803)

Rho GDP-dissociation inhibitor 1 (UniProt P19803): 10 experimental structures and 1 predicted model on GenesisL1, 3 ligands bound, 3 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
P19803
Protein
Rho GDP-dissociation inhibitor 1
Experimental structures
10
Predicted models
1
Ligands
3
Pockets
3 · 1 record with a druggable one

Structures

11 records of P19803 in the MolNFT archive: 10 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1AJWStructure of rhogdi: a C-terminal binding domain targets an N-terminal inhibitory peptide to…solution nmrA——
1AJWStructure of rhogdi: a C-terminal binding domain targets an N-terminal inhibitory peptide to…solution nmrA——
1DOAStructure of the rho family gtp-binding protein cdc42 in complex with the multifunctional regulator…x-ray diffractionB——
1DOAStructure of the rho family GTP-binding protein CDC42 in complex with the multifunctional regulator…x-ray diffractionB——
1GDFStructure of rhogdi: a C-terminal binding domain targets an N-terminal inhibitory peptide to…solution nmrA——
1GDFStructure of rhogdi: a C-terminal binding domain targets an N-terminal inhibitory peptide to…solution nmrA——
5FR1Double acetylated RhoGDI-alpha in complex with RhoA-GDPx-ray diffractionBMG—
5FR1Double acetylated rhogdi-alpha in complex with rhoa-GDPx-ray diffractionB——
5FR2Farnesylated RhoA-GDP in complex with RhoGDI-alpha, lysine acetylated at K178x-ray diffractionBFAR, BGC3 (best 0.79)
5FR2Farnesylated rhoa-GDP in complex with rhogdi-alpha, lysine acetylated at K178x-ray diffractionB——
P19803AlphaFold monomer V2.0 prediction for rho GDP-dissociation inhibitor 1 (P19803)predictedA——

Ligands

  • BGC · beta-D-glucopyranose · in 1 record
  • FAR · Farnesyl · in 1 record
  • MG · Magnesium ion · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.